Want to see JP:206A full AI Analyst Report?
PRISM BioLab Co. LTD (206A) Financial Statements
PRISM BioLab Co. LTD Financial Overview
PRISM BioLab Co. LTD's market cap is currently $4.89B. The company's EPS TTM is ―; its P/E ratio is -5.57; PRISM BioLab Co. LTD has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Sep 25 | Sep 24 | Sep 23 | Sep 22 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 677.33M | $ 305.62M | $ 112.93M | $ 554.40M |
| Gross Profit | $ 269.76M | $ 160.54M | $ 80.31M | $ 535.14M |
| Operating Income | $ -774.45M | $ -782.39M | $ -496.87M | $ 66.68M |
| EBITDA | $ -831.28M | $ -1.05B | $ -488.13M | $ 67.89M |
| Net Income | $ -833.70M | $ -1.05B | $ -526.91M | $ 72.96M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 2.92B | $ 4.39B | $ 1.13B | $ 1.69B |
| Total Assets | $ 3.09B | $ 4.53B | $ 1.21B | $ 1.74B |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -2.92B | $ -4.39B | $ -1.13B | $ -1.69B |
| Total Liabilities | $ 376.86M | $ 1.03B | $ 63.41M | $ 65.23M |
| Stockholders' Equity | $ 2.71B | $ 3.50B | $ 1.15B | $ 1.67B |
| Cash Flow | ||||
| Free Cash Flow | $ -1.53B | $ -61.55M | $ -548.40M | $ 97.25M |
| Operating Cash Flow | $ -1.47B | $ 150.14M | $ -513.81M | $ 102.96M |
| Investing Cash Flow | $ -69.01M | $ -244.19M | $ -40.38M | $ -7.87M |
| Financing Cash Flow | $ 33.59M | $ 3.37B | $ 0.00 | $ 110.87M |
Currency in JPY